Enzyme immunoassay for the measurement of human tenascin-C on the Bayer Immuno 1(TM) analyzer

Clinical Biochemistry

Volumn 33, Issue 1, 2000, Pages 7-13

  Ropers, Tanja ^a   Kroll, Werner ^a   Becka, Michael ^a   Voelker, Michael ^a   Burchardt, Elmar R ^a   Schuppan, Detleff ^b   Gehrmann, Mathais ^a  

^a BAYER AG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Biochemical marker; Detection limits; Enzyme immunoassay; Extracellular matrix; Liver fibrosis; Precision; Reference range

Indexed keywords

BIOCHEMICAL MARKER; TENASCIN;

ARTICLE; CALIBRATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; HUMAN; LINEAR SYSTEM; LIVER FIBROSIS; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BIOLOGICAL AVAILABILITY; BLOOD PRESERVATION; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; REFERENCE VALUES; TENASCIN;

EID: 0034062660     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00083-1     Document Type: Article

References (29)

1. Erickson H.P., Bourdon M.A. Tenascin an extracellular matrix protein prominent in specialised embryonic tissues and tumors . Annu Rev Cell Biol. 5:1989;71-92.
2. Chiquet-Ehrismann R. Tenascins, a growing family of extracellular matrix proteins. Experientia. 51:1995;853-862.
3. Vollmer G. Biologic and oncologic implications of tenascin-C/hexabrachion proteins. Crit. Rev Oncol Hematol. 25:1997;187-210.
4. Erickson H.P. tenascin-C, tenascin-R and tenascin-X a family of talented proteins in search of functions . Curr Opin Cell Biol. 5:1993;869-876.
5. Siri A., Carnemolla B., Saginati M., et al. Human tenascin primary structure, pre-mRNA splicing patterns and localization of the epitopes recgnized by two monoclonal antibodies . Nucleic Acid Res. 19:1991;525-531.
6. Siri A., Allemanni G., Gaggero B., Zardi L. Different human tenascin-C variants in the extracellular matrix of cultured human fibroblasts. Biochem Cell Biol. 74:1996;863-866.
7. Herlyn M., Graeven U., Speicher D., et al. Characterization of tenascin secreted by human melanoma cells. Cancer Res. 51:1991;4853-4858.
8. Yoshida J., Wakabayashi T., Okamoto S., et al. Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumor. J Neurol Neurosurg Psychiatry. 57:1994;1212-1215.
9. Hauptmann S., Zardi L., Siri A., et al. Extracellular matrix proteins in colorectal carcinomas. Lab Invest. 2:1995;172-182.
10. Ishihara A., Yoshida T., Tamaki H., Sakakura T. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res. 1:1995;1035-1041.
11. Riedl S., Bodenmüller H., Hinz U., et al. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer. 64:1995;65-69.
12. Riedl S., Kadmon M., Tandara A., Hiz U., Möller P., Faissner A. tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa. Anticancer Res. 17:1997;3165-3166.
13. Chevalier X., Groult N., Larget-Piet B., Zardi L., Hornebeck W. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 37:1994;1013-1022.
14. Van Eyken P., Sciot R., Desmet V.J. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. J Hepatol. 11:1990;43-52.
15. Van Eyken P., Geerts A., De Bleser P., et al. Localisation and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver. Hepatology. 15:1992;909-916.
16. KaarteenahoWiik R., Mertaniemi P., Sajanti E., Soini Y., Paakko P. Tenascin is increased in eptithelial lining fluid in fibrotic lung disorders. Lung. 176:1998;371-380.
17. Kimura S., Ishida S., Kuniyoshi M., et al. Determination of tenascin in human serum by the use of a new enzyme immunoassay. Biomed Res. 14:1993;203-208.
18. Washizu K., Kimura S., Hiraiwa H., Matsunaga K., Kuwabara M., Ariyoshi Y., Kato K., Takeuchi K. Development and application of an enzyme immunoassay for tenascin. Clin Chim Acta. 218:1993;15-22.
19. Ylätupa S., Mertaniemi P., Haglund C., Partanen P. Enzyme immunoassay for quantification of tenascin in biologic samples. Clin Biochem. 28:1995;263-268.
20. Yamauchi M., Mizuhara Y., Maezawa Y., Toda G. Serum tenascin levels in chronic liver disease. Liver. 14:1994;148-153.
21. Libuda P., Oesterling C., Aksü T., et al. Tenascin is a serum marker of lobular but not portal fibrogenesis in chronic liver diseases. Hepatology. 22:1995;1050. (abstract).
22. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predifined specificity. Nature. 256:1975;495-497.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
24. Towbin H., Stehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications . Proc Natl Acad Sci USA. 76:1979;4350-4354.
25. Fraser C.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Critical Rev Clin Lab Sci. 27:1989;409-437.
26. Solberg HE, for the Expert Panel on the Theory of Reference Values. The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1984; 137: 97-114.
27. Saga Y., Yagi T., IkawaY Sakakura T., Aizawa S. Mice develop normally without tenascin. Genes Dev. 6:1992;1821-1831.
28. Lawniczak M., Sikora J., Kania P., Zeromski J. The search for tumor-associated proteins in pleural effusions by means of monoclonal antibodies and a dot blot assay. Lung. 170:1992;65-74.
29. Schenk S., Muser J., Vollmer G., Chiquet-Ehrismann R. tenascin-C in serum a questionable tumour marker . Int J Cancer. 61:1995;443-449.